Dear Padmini
VPPAG is currently consulting on a paper on the generic Preferred Product
Profile (gPPP) for new vaccines used by national programmes in developing
countries. The document is currently open for consultation until July 15th. (see attached)
Kindly find it at our site:
http://sites.google.com/site/vppagp (main page)
http://sites.google.com/site/vppagp/gppp (document page)
Thanks for alerting the readership that we are seeking comments on this.
Thanks
Oz
Dr Osman David Mansoor [] Public Health Physician
Senior Adviser EPI (New Vaccines) []United Nations Children's Fund [] 3 UN
Plaza, New York, NY 10017 (room 840)
Phone: +1 212 326 7410 (direct) Fax: +1 212 8246460
Email: [[email protected]][email protected][/email]
##text##
Following a month long public consultation process, the Vaccine Presentation and Packaging Advisory Group (VPPAG) has released version 2.1 of the Generic Preferred Product Profile (gPPP). This version incorporates all comments received to date from a wide range of partners and stakeholders, including industry, NGOs, UN agencies and public health experts.
The gPPP outlines a set of generic recommendations for future vaccines. The gPPP also includes a work programme which identifies areas in which more information is needed prior to a recommendation being made. VPPAG will now focus its efforts on gathering the necessary data to be able to make recommendations in these areas. As such, the gPPP remains in draft form, with a new version expected in 2010 as progress on the work programme is made.
Simona Zipursky
##text##
- Page :
- 1
There are no replies made for this post yet.